TFLLR-NH2 (TFA) is a selective PAR1 agonist with an EC50 of 1.9 μM.
CAT No: 10-101-204
CAS No:1313730-19-6
Synonyms/Alias:TFLLR-NH2(TFA);TFLLR-NH2 TFA;1313730-19-6;(2S)-N-[(2S)-1-[[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanamide;2,2,2-trifluoroacetic acid;HY-P0226A;DA-78364;MS-31362;CS-0058948;G13320;TFLLR-NH2 TFA, TFLLR-NH2 trifluoroacetate salt;TFLLR-NH2 trifluoroacetate salt, >98% (HPLC);(2S)-2-[(2S)-2-[(2S,3R)-2-AMINO-3-HYDROXYBUTANAMIDO]-3-PHENYLPROPANAMIDO]-N-[(1S)-1-{[(1S)-4-CARBAMIMIDAMIDO-1-CARBAMOYLBUTYL]CARBAMOYL}-3-METHYLBUTYL]-4-METHYLPENTANAMIDE; TRIFLUOROACETIC ACID;(S)-2-((S)-2-((2S,3R)-2-Amino-3-hydroxybutanamido)-3-phenylpropanamido)-N-((S)-1-(((S)-1-amino-5-guanidino-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-4-methylpentanamide 2,2,2-trifluoroacetate;
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More